TNFSF10 and glioblastoma: However, recent encouraging studies with different compounds, which regulate the components of the TRAIL-dependent apoptotic signaling mechanism, show that targeting the TRAIL pathway is a promising therapeutic strategy for glioblastoma treatment [28].